2d ), although differences between subtypes did not reach statistical significance (Supplementary Table 6a ).
← all excerpts
Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles.
1
—
—